Investor Relations

Stock Information

Symbol

Nasdaq: VTGN

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

VistaGen Therapeutics (Nasdaq: VTGN) is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen's CNS drug candidates, PH94B, PH10, and AV-101, has a differentiated mechanism of action, a favorable safety profile in all clinical studies to date, and therapeutic potential in multiple CNS markets.

Contact Information

VistaGen Therapeutics
Mark Flather
Vice President, Investor Relations
+1(650) 577-3617
mflather@vistagen.com

Transfer Agent
Computershare, Inc.
P.O. BOX 30170
College Station, TX 77842
(800) 368-5948
www-us.computershare.com